Nippon Life Global Investors Americas’s DexCom DXCM Stock Holding History

Nippon Life Global Investors Americas’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.6M	Sell	53,400 -11,870	-18%	-$791K	0.14%	66
2026 Q1	$4.1M	Hold	65,270	–	–	0.18%	67
2025 Q4	$4.33M	Sell	65,270 -10,990	-14%	-$711K	0.18%	64
2025 Q3	$5.13M	Buy	76,260 +12,160	+19%	+$962K	0.22%	63
2025 Q2	$5.6M	Buy	+64,100	New	+$5.02M	0.25%	62
2024 Q3	–	Sell	-46,700	Closed	-$5.29M	–	112
2024 Q2	$5.29M	Hold	46,700	–	–	0.23%	63
2024 Q1	$6.48M	Buy	46,700 +17,840	+62%	+$2.24M	0.3%	58
2023 Q4	$3.58M	Hold	28,860	–	–	0.2%	70
2023 Q3	$2.69M	Buy	+28,860	New	+$3.25M	0.17%	80
2022 Q2	–	Sell	-78,120	Closed	-$9.99M	–	142
2022 Q1	$9.99M	Buy	78,120 +28,800	+58%	+$3.15M	0.53%	53
2021 Q4	$6.62M	Buy	+49,320	New	+$7.09M	0.31%	87

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Nippon Life Global Investors Americas's DXCM Position: Q2 2026 in Review

Nippon Life Global Investors Americas reduced its DexCom (DXCM) stake by 18% in Q2 2026, selling an estimated $791K and leaving 53,400 shares worth $3.6M. The position accounts for 0.14% of the portfolio, ranked #66.

Nippon Life Global Investors Americas first reported a position in DXCM in Q4 2021 and has held it in 11 quarters since. The position peaked at $9.99M in Q1 2022. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Nippon Life Global Investors Americas held 53,400 shares of DexCom worth $3.6M as of Q2 2026.
Nippon Life Global Investors Americas sold 11,870 DexCom shares in Q2 2026, an estimated $791K.
DexCom made up 0.14% of Nippon Life Global Investors Americas's portfolio in Q2 2026, its #66 holding.
Nippon Life Global Investors Americas first reported a position in DexCom in Q4 2021 and has held it in 11 quarters since.
Nippon Life Global Investors Americas's DexCom position peaked at $9.99M in Q1 2022.
968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Nippon Life Global Investors Americas's 13F filing for Q2 2026, filed 6 Aug 2026.